Jane Street
SRNE

Jane Street’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Jane Street’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,600
Closed -$17.4K – 10496
2022
Q4 		$17.4K Sell
19,600
-52,800
-73% -$70K ﹤0.01% 8639
2022
Q3 		$114K Sell
72,400
-15,700
-18% -$35.6K ﹤0.01% 8581
2022
Q2 		$177K Buy
88,100
+6,300
+8% +$10.9K ﹤0.01% 8285
2022
Q1 		$191K Sell
81,800
-131,600
-62% -$410K ﹤0.01% 9064
2021
Q4 		$992K Buy
213,400
+73,000
+52% +$453K ﹤0.01% 5922
2021
Q3 		$1.07M Sell
140,400
-196,900
-58% -$1.67M ﹤0.01% 5778
2021
Q2 		$3.27M Buy
337,300
+31,300
+10% +$249K ﹤0.01% 3420
2021
Q1 		$2.53M Sell
306,000
-65,100
-18% -$687K ﹤0.01% 3579
2020
Q4 		$2.53M Sell
371,100
-216,500
-37% -$1.74M ﹤0.01% 3110
2020
Q3 		$6.55M Sell
587,600
-114,200
-16% -$1.05M ﹤0.01% 1584
2020
Q2 		$4.41M Buy
+701,800
New +$2.69M ﹤0.01% 2008

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Jane Street's SRNE Position: Q1 2023 in Review

Jane Street sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 731,024 shares — an estimated $648K sold.

Jane Street first reported a position in SRNE in Q1 2014 and held it in 17 quarters. The position peaked at $9.32M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Jane Street reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 731,024 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $648K.
  • Jane Street first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 17 quarters.
  • Jane Street's Sorrento Therapeutics, Inc. position peaked at $9.32M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.